Evidence map›Paper›PMID 37465051›Full record

ArticleInternational journal of public health2023

Real-World Utilization, Barriers, and Factors Associated With the Targeted Treatment of Metastatic Colorectal Cancer Patients in China: A Multi-Center, Hospital-Based Survey Study.

Yin Liu, Xi Zhang, Hui-Fang Xu, Ji-Hai Shi, Yu-Qian Zhao, Ling-Bin Du, Yun-Yong Liu, Wen-Jun Wang, He-Lu Cao, Li Ma and 12 more

Open access · goldAbstract readMulticenter Study
PubMed Full text at PMC Publisher
In one paragraph

Article in International journal of public health, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.6field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors at 19 institutions in 1 country.

Yin LiuDepartment of Cancer Epidemiology, Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital, Henan Engineering Research Center of Cancer Prevention and Control, Henan International Joint Laboratory of Cancer Prevention, Zhengzhou, China.
Xi ZhangKey Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Beijing Office for Cancer Prevention and Control, Peking University Cancer Hospital and Institute, Beijing, China.
Hui-Fang XuDepartment of Cancer Epidemiology, Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital, Henan Engineering Research Center of Cancer Prevention and Control, Henan International Joint Laboratory of Cancer Prevention, Zhengzhou, China.
Ji-Hai ShiThe Clinical Epidemiology of Research Center, Department of Dermatological, The First Affiliated Hospital of Baotou Medical College, Baotou, China.
Yu-Qian ZhaoSichuan Cancer Hospital and Institute, Sichuan Cancer Center, School of Medicine, University of Electronic Science and Technology of China, Chengdu, China.
Ling-Bin DuDepartment of Cancer Prevention, The Cancer Hospital of the University of Chinese Academy of Sciences, Zhejiang Cancer Hospital, Hangzhou, China.
Yun-Yong LiuLiaoning Office for Cancer Control and Research, Cancer Hospital of China Medical University, Liaoning Cancer Hospital and Institute, Shenyang, China.
Wen-Jun WangSchool of Nursing, Jining Medical University, Jining, China.
He-Lu CaoDepartment of Preventive Health, Xinxiang Central Hospital, Xinxiang, China.
Li MaPublic Health School, Dalian Medical University, Dalian, China.
Juan-Xiu HuangDepartment of Gastroenterology, Wuzhou Red Cross Hospital, Wuzhou, China.
Ji CaoDepartment of Cancer Prevention and Control Office, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, China.
Li LiDepartment of Clinical Research, The First Affiliated Hospital, Jinan University, Guangzhou, China.
Yan-Ping FanState Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China.
Xiao-Fen GuDepartment of Student Affairs, Affiliated Tumor Hospital, Xinjiang Medical University, Ürümqi, Xinjiang, China.
Chang-Yan FengChongqing Key Laboratory of Translational Research for Cancer Metastasis and Individualized Treatment, Chongqing University Cancer Hospital, Chongqing, China.
Qian ZhuSchool of Public Health and Management, Chongqing Medical University, Chongqing, China.
Xiao-Hui WangDepartment of Public Health, Gansu Provincial Cancer Hospital, Lanzhou, China.
Jing-Chang DuSchool of Public Health, Chengdu Medical College, Chengdu, China.
Jian-Gong ZhangDepartment of Cancer Epidemiology, Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital, Henan Engineering Research Center of Cancer Prevention and Control, Henan International Joint Laboratory of Cancer Prevention, Zhengzhou, China.
Shao-Kai ZhangDepartment of Cancer Epidemiology, Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital, Henan Engineering Research Center of Cancer Prevention and Control, Henan International Joint Laboratory of Cancer Prevention, Zhengzhou, China.
You-Lin QiaoDepartment of Cancer Epidemiology, Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital, Henan Engineering Research Center of Cancer Prevention and Control, Henan International Joint Laboratory of Cancer Prevention, Zhengzhou, China.
Shanghai Cancer Institute · CNChina Medical University · CNBaotou Medical College · CNChengdu Medical College · CNChina Foreign Affairs University · CNChinese Academy of Medical Sciences & Peking Union Medical College · CNChinese Center For Disease Control and Prevention · CNChinese Preventive Medicine Association · CNChongqing Medical University · CNChongqing University · CNDalian Medical University · CNGansu Provincial Hospital · CNJining Medical University · CNPeking University · CNShanghai Clinical Research Center · CNSun Yat-sen University · CNUniversity of Chinese Academy of Sciences · CNUniversity of Electronic Science and Technology of China · CNWuzhou Red Cross Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Colonic NeoplasmsColorectal NeoplasmsCosts and Cost AnalysisHospitalsHumansQuality of Lifeassociated factorsbarriersmetastatic colorectal cancertargeted treatmentutilization

Identifiers

PMID37465051
PMCPMC10351535
OpenAlexW4382937442

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.